An open-label, randomized, parallel-group comparison study on the effects of the "e-Diabetes Diary" on self-management efficacy for type 2 diabetics
Not Applicable
- Conditions
- 30 Type 2 diabetics who use their smartphones daily
- Registration Number
- JPRN-UMIN000017719
- Lead Sponsor
- Tokushima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Those whose HbA1c has worsen by more than 1% over the last 3 months, and/or has failed to reach treatment goals and assessed to need immediate care. Those who are undergoing intensive cardio-vascular, cerebrovascular and kindney disease treatment. Those who are participating in other interventional clinical trials Those for other reasons, who have been assessed to be not fit by their doctor,
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method After receiving instructions from their doctor, patients will self-manage their diabetes using the "e-diabetes diary" for 3 months. At the end of 3 months, the changes in the patients' understanding and knowledge of their self-management activities will be measured by interview and questionnaire.
- Secondary Outcome Measures
Name Time Method After receiving instructions from their doctor, patients will self-manage their diabetes using the "e-diabetes diary" for 3 months. At the end of 3 months, the following items will be measured. The changes in the patients' self-management activities will be measured by interview and questionnaire. The changes in diet will be measured by food frequency questionnaire. The changes in exercise will be measured using a pedometer. The changes in blood glucose level management will be assessed by measuring HbA1c. The changes in obesity level will be assessed by measuring weight, BMI and body composition. The changes in diabetes related complications will be assessed by measuring triglyceride, total cholesterol, HDL cholesterol, BUN, Creatinine, AST, ALT, urinary albumin excretion rate and e-GFR.